Spots Global Cancer Trial Database for Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Official Title: Phase II Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Study ID: NCT04305548
Conditions
Interventions
Study Description
Brief Summary: Prospective, uncontrolled, investigator-initiated, phase II clinical study to explore the activity of trabectedin in a population of patients aged ≥16 years with progressive, advanced (locally advanced or metastatic)
Detailed Description: Prospective, uncontrolled, multicenter, Italian, investigator-initiated, phase II clinical study to explore the activity of trabectedin in a population of patients aged ≥16 years with progressive, advanced (locally advanced or metastatic), HEY1-NCOA2 positive MCS) , pre-treated with anthracycline-based chemotherapy.
Keywords
Eligibility
Minimum Age: 16 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Nuovo Ospedale di Prato, Prato, Firenze, Italy
Policlinico Universitario Campus Biomedico, Roma, RM, Italy
Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo, Torino, Italy
Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors, Bologna, , Italy
Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, , Italy
Ospedale Giaccone, Palermo, , Italy
Istituti Fisioterapici Ospitalieri - Ospedale Regina Elena, Roma, , Italy
Contact Details
Name: Silvia Stacchiotti, MD
Affiliation: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
